Markets
English
4151
 

Trade Kyowa Kirin Co., Ltd. - 4151 CFD

1m
5m
15m
30m
1H
4H
1D
1W

Trader sentiment

% Buyers % Sellers
  • Long position overnight fee -0.0220%
    Margin $1,000.00
    Overnight feeCharges from borrowed part ($-0.88) -0.0220 %
  • Short position overnight fee -0.0224%
    Margin $1,000.00
    Overnight feeCharges from borrowed part ($-0.90) -0.0224 %
  • Overnight fee time 22:00 (UTC)
  • Min traded quantity 1
  • Currency JPY
  • Margin 20%
  • Stock exchange Japan
  • Trading hours (UTC)
    Mon - Fri: 00:00 - 02:30
    03:30 - 06:00
  • Commission on trade 0%

Kyowa Kirin Co., Ltd., a specialty pharmaceutical company, manufactures and markets pharmaceuticals focused on the therapeutic areas of oncology, nephrology, central nervous system, and immunology worldwide. Its products include ABSTRAL, a sublingual formulation of fentanyl used for the management of episodes of breakthrough pain experienced by cancer patients; ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; GRAN, a human colony-stimulating factor; and G-LASTA/Peglasta/Neulasta for chemotherapy-induced febrile neutropenia. The company's products also comprise LEUNASE for acute lymphoblastic leukemia; Mitomycin-C, an anticancer antibiotic; Moventig, an oral once daily peripherally acting mu-opioid receptor antagonist for the treatment of opioid induced constipation in adult patients; PecFent, a nasally administrated spray; POTELIGEO, a humanized monoclonal antibody that targets CC chemokine receptor 4; and REGPARA, an agent for the treatment of secondary hyperparathyroidism. In addition, it offers Romiplate/Nplate, a genetically recombinant protein, which stimulates platelet production through the stimulation of thrombopoietin receptors; and SANCUSO for the treatment of nausea and vomiting. The company was formerly known as Kyowa Hakko Kirin Co., Ltd. and changed its name to Kyowa Kirin Co., Ltd. in June 2019. The company was founded in 1949 and is headquartered in Tokyo, Japan. Kyowa Kirin Co., Ltd. is a subsidiary of Kirin Holdings Company, Limited.

Trade shares with leverage

Shares are available to trade with up to 5:1 leverage. Start trading with as little as $100 to control a position of $500

Shares CFDs

  • Trade 24/5 on a wide range of shares

  • Trading opportunities in both a rising and falling market

Profit and loss control

You can easily define Stops and Limits to request positions to close at a specified price.

Set up price alerts to be informed of big moves.

You might be interested in

Still looking for a broker you can trust?


Join the 150,000+ traders worldwide that chose to trade with Capital.com

1. Create your account

2. Make your first deposit

3. You’re all set. Start trading